3336-58-1

Basic information

• Product Name: AMMONIUM TRIFLUOROACETATE
• Synonyms: AMMONIUM TRIFLUORACETATE;AMMONIUM TRIFLUOROACETATE;TRIFLUOROACETIC ACID AMMONIUM SALT;Acetic acid, trifluoro-, ammonium salt;Ammonium trifluoroacetate 98%;Ammoniumtrifluoroacetate98%;Trifluoroacetic acid, ammonium salt,98%;Trifluoroacetic acid, ammonium salt, Ammonium 2,2,2-trifluoroethanoate
• CAS NO: 3336-58-1
• Molecular Formula: C₂HF₃O₂*H₃N
• Molecular Weight: 131.05
• EINECS: 222-072-4
• Mol File: 3336-58-1.mol
• Article Data: 9

Chemical Properties

• Melting Point: 123-125 °C(lit.)
• Boiling Point: 72.2 °C at 760 mmHg
• Flash Point: 49.9 °C
• Appearance: White to off-white/Crystalline Powder or Crystals
• Density: 1.3887 (estimate)
• Solubility: H2O: 0.1 g/mL at 25 °C, clear, colorless
• Water Solubility: Soluble in Water.
• Sensitive: Hygroscopic
• CAS DataBase Reference: AMMONIUM TRIFLUOROACETATE(CAS DataBase Reference)
• NIST Chemistry Reference: AMMONIUM TRIFLUOROACETATE(3336-58-1)
• EPA Substance Registry System: AMMONIUM TRIFLUOROACETATE(3336-58-1)

Safety Data

• Hazard Codes: Xi
• Statements: 36/37/38
• Safety Statements: 26-36-37/39
• WGK Germany: 3
• F: 3-10
• Hazardous Substances Data: 3336-58-1(Hazardous Substances Data)

Usage

Chemical Properties

White to off-white crystals or crystalline powder

Uses

Used in the synthesis of hexafluoro-2-aminopentan-4-one ligand and in tuning and calibrating new liquid chromatography/mass spectrometry systems. Applications of ammonium trifluoroacetate as an additive for elution of chiral acids and bases from derivatized polysaccharide stationary phases

InChI:InChI=1/C2HF3O2/c3-2(4,5)1(6)7/h(H,6,7)

Upstream product

• 144864-94-8 5,5,5-trifluoro-4-hydroxy-pent-3-en-2-one 
• 253127-02-5 9-{(3aR,4R,6S, 6aR)-6-[5-(tert-butyl)-1,3,4-oxadiazol-2-yl]-2,2-dimethyltetrahydrofuro[3,4-d][1,3]dioxol-4-yl}-N-(4-chloro-2-fluorophenyl)-9H-purin-6-amine 
• 144864-93-7 1-phenyl-4,4,4-trifluorobutane-1,3-dione 
• 404-24-0 2,2,2-trifluoro-N-phenylacetamide 

Downstream Products

• 53267-69-9 N-Trifluoracetyl-2,5-cyclohexadien-1-alanin-methylamid 
• 107996-59-8 3-Hydroxymethyl-8-oxo-7-(2-thiophen-2-yl-acetylamino)-5-thia-1-aza-bicyclo[4.2.0]oct-2-ene-2-carboxylic acid 4-nitro-benzyl ester 
• 459216-87-6 5-(2-amino-1-hydroxy-2-m-tolyl-ethyl)-1-cyclopentyl-3-methyl-1,3-dihydro-benzoimidazol-2-one hydrochloride 
• 127933-63-5 (diisopropoxyphosphoryl)formic acid 4-nitrophenylhydrazide 
• 920-66-1 1,1,1,3',3',3'-hexafluoro-propanol 

Relevant articles and documents

POLYMORPH

(2S,3S,4R,5R)-2-(5-tert-butyl-[1,3,4]-oxadiazol-2-yl)-5-[6-(4-chloro-2-fluorophenylamino)-purin-9-yl]-tetrahydrofuran-3,4-diol in polymorphic form III.

METHOD FOR TREATING FUNGAL INFECTIONS

-

Synergistic combination comprising cryptophycin derivatives and microtubule synergizing agents

A composition for providing a synergistic treatment for cancer comprising a compound selected from the group consisting of Compound I, Compound II, Compound III, Compound IV and Compound V and one or more microtubule synergizing agents is disclosed. Also, a method of treating cancer using a therapeutically effective amount of a compound selected from the group consisting of Compound I, Compound II, Compound III, Compound IV and Compound V and one or more microtubule synergizing agents or radiation therapy is also disclosed.